Article Versions Notes

Esposito Abate R, Pasquale R, Sacco A, Piccirillo MC, Morabito A, Bidoli P, Finocchiaro G, Chiari R, Foltran L, Buosi R, et al. Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib. Cancers. 2019; 11(10):1431. https://doi.org/10.3390/cancers11101431

Esposito Abate, Riziero, Raffaella Pasquale, Alessandra Sacco, Maria Carmela Piccirillo, Alessandro Morabito, Paolo Bidoli, Giovanna Finocchiaro, Rita Chiari, Luisa Foltran, Roberta Buosi, and et al. 2019. "Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib" Cancers 11, no. 10: 1431. https://doi.org/10.3390/cancers11101431

Esposito Abate, R., Pasquale, R., Sacco, A., Piccirillo, M. C., Morabito, A., Bidoli, P., Finocchiaro, G., Chiari, R., Foltran, L., Buosi, R., Tiseo, M., Giannetta, L., Battiloro, C., Fasola, G., Romano, G., Ciuffreda, L., Frassoldati, A., de Marinis, F., Cappuzzo, F., & Normanno, N. (2019). Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib. Cancers, 11(10), 1431. https://doi.org/10.3390/cancers11101431